Gain Therapeutics Inc Share Price

NASDAQ: GANX

Small Cap

$1.66

-0.06

(-3.49%)

as on September 13, 2025 at 1:29 am IST

$₹

Gain Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$1.65
Day's Price Range
$1.75
$1.66
0.60%
Downside
5.42%
Upside
52 Week's Low
52 Week's High
$1.36
52-Week Price Range
$3.19
$1.66
18.07%
Downside
92.17%
Upside

Gain Therapeutics Inc share price movements today

Previous Close: $1.72
Open: $1.72
Volume: 894.5K
Day's Low - High: $1.65 - $1.75
52 Week Low - High: $1.36 - $3.19

Gain Therapeutics Inc Historical Returns

1 Month Return: -4.05 %
3 Month Return: -4.05 %
1 Year Return: + 13.31 %
3 Year Return: -57.44 %
5 Year Return: 0 %

Gain Therapeutics Inc Stock Fundamentals & Key Indicators

Check Gain Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$59.7M

EPS (TTM)

-0.6667

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.23

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-17.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

24097500.00%

Gain Therapeutics Inc Stock Valuation

Track how Gain Therapeutics Inc P/E has moved over time to understand its valuation trends.

Gain Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (-1.23x)

September 15, 2025

Highest (0.00x)

September 15, 2025

LowHigh

Today’s Price to Earnings Ratio: -1.23x

Gain Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gain Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Gain Therapeutics Inc	BUY	$59.7M	NA	-1.23	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Gain Therapeutics Inc Stock including INR - Dollar returns

The Gain Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Gain Therapeutics Inc investment value today

Current value as on today

₹1,17,911

Returns

₹17,911

(+17.91%)

Returns from Gain Therapeutics Inc Stock

₹12,925 (+12.93%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Gain Therapeutics Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Gain Therapeutics Inc. Average target price of $7.71

Gain Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Gain Therapeutics Inc.

What analysts predicted

78.47%UPSIDE

Target Price

$7.71

Current Price

$1.66

Analyzed by

11 Analysts

Target

$7.71

Gain Therapeutics Inc target price $7.71, a slight upside of 78.47% compared to current price of $1.66. According to 11 analysts rating.

Gain Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	-	-	0	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-5	-7	-4	-4	-4	-8	-4	-3	-4	-5
EBITDA	-5	-7	-4	-4	-4	-8	-4	-3	-4	-5
Interest Expense	0	0	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-7	-4	-4	-3	-8	-4	-3	-4	-5
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-5	-7	-4	-4	-4	-8	-4	-3	-4	-5
Net Profit Margin	-9310.11%	0.00%	0.00%	-7290.08%	0.00%	0.00%	0.00%	-4581.88%	0.00%	0.00%

Gain Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0	-
Gross Profit	0	0	-2	-6	0	0	0
Operating Income	-1	-2	-3	-13	-17	-22	-20
EBITDA	-1	-2	-3	-13	-17	-22	-19
Interest Expense	-	0	0	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-1	-2	-3	-13	-17	-22	-19
Income Tax Expense	0	0	0	0	0	0	0
Net Income	-1	-2	-3	-13	-17	-22	-20
Net Profit Margin	-5364.36%	-5310.88%	-12387.67%	-8418.86%	-12555.13%	-40354.33%	0.00%

Gain Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-7	-4	-4	-4	-8	-4	-3	-4	-5
Operating Cash Flow	-5	-3	-5	-3	-5	-6	-3	-3	3
Investing Cash Flow	3	1	3	3	2	-	0	-	-
Financing Cash Flow	2	0	9	0	10	0	2	2	2
Change in Cash	0	-2	7	-1	6	-4	-1	-1	-2

Gain Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-3	-13	-17	-22	-20
Operating Cash Flow	-1	-3	-12	-14	-18	-18
Investing Cash Flow	0	0	0	-14	10	4
Financing Cash Flow	1	10	41	0	12	13
Change in Cash	0	7	29	-29	4	-1

Global Institutional Holdings in Gain Therapeutics Inc

Funds	Holdings
JONES FINANCIAL COMPANIES LLLP	1.24%
Geode Capital Management, LLC	0.82%
Vanguard Group Inc	0.74%
Marshall Wace Asset Management Ltd	0.57%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.	0.52%

See all

Insights on Gain Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 180.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 62.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, GANX stock has moved down by -5.1%

About Gain Therapeutics Inc

gain therapeutics is a preclinical stage biotech company specializing in the discovery of new drugs for orphan diseases. the company targets inborn errors of metabolism; a group of rare diseases of genetic origin with a high unmet medical need. gain therapeutics is also working on a new class of compounds: non-competitive pharmacological chaperones, identified through its innovative proprietary platform – see-tx. the gain therapeutics team is made up of a group of drug discovery and development experts with several decades of experience in biotech and pharma.

Organisation	Gain Therapeutics Inc
Headquarters	4800 Montgomery Lane, Bethesda, MD, United States, 20814
CEO	Mr. Gene Mack M.B.A.
E-voting on shares	Click here to vote

Key Management of Gain Therapeutics Inc

Name	Title
Mr. Gene Mack M.B.A.	President, CEO & Director
Mr. Gianluca Fuggetta	Senior VP of Finance & Principal Financial Officer
Dr. Terenzio Ignoni Pharm.D.	Senior Vice President of Technical Operations
Dr. Joanne Taylor Ph.D.	Senior Vice President of Research
Dr. Jonas Hannestad M.D., Ph.D.	Chief Medical Officer
Dr. Khalid Islam Ph.D.	Chairman & Founder

FAQs

What is Gain Therapeutics Inc share price today?

Gain Therapeutics Inc share price today is $1.66 as on September 13, 2025 at 1:29 am IST at the close of the market. Gain Therapeutics Inc share today touched a day high of $1.75 and a low of $1.65.

What is the 52 week high and 52 week low for Gain Therapeutics Inc share?

Gain Therapeutics Inc share touched a 52 week high of $3.19 on October 17, 2024 and a 52 week low of $1.36 on September 18, 2024. Gain Therapeutics Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $1.66,which is 47.96% down from its 52 week high and 22.06% up from its 52 week low.

What is Gain Therapeutics Inc's market capitalisation today?

Gain Therapeutics Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Gain Therapeutics Inc Stock (GANX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Gain Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gain Therapeutics Inc Shares that will get you 0.9036 shares as per Gain Therapeutics Inc share price of $1.66 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Gain Therapeutics Inc Stock (GANX) from India?

Indian investors can start investing in Gain Therapeutics Inc (GANX) shares with as little as ₹88.141 or $1 (as of September 15, 2025 at 6:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Gain Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 6:38 pm IST). Based on Gain Therapeutics Inc share’s latest price of $1.66 as on September 13, 2025 at 1:29 am IST, you will get 6.0241 shares of Gain Therapeutics Inc. Learn more about fractional shares .